Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture

BACKGROUND: Positive anticyclic citrullinated peptide (anti-CCP+) is associated with bone loss in patients with rheumatoid arthritis (RA). However, whether overall positivity or specific levels of anti-CCP are associated with prevalent fracture or a 10-year probability of fracture remains unclear. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Tien-Tsai, Yu, Shan-Fu, Su, Fu-Mei, Chen, Yin-Chou, Su, Ben Yu-Jih, Chiu, Wen-Chan, Hsu, Chung-Yuan, Chen, Jia-Feng, Ko, Chi-Hua, Lai, Han-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791167/
https://www.ncbi.nlm.nih.gov/pubmed/29382355
http://dx.doi.org/10.1186/s13075-018-1515-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791167/
https://www.ncbi.nlm.nih.gov/pubmed/29382355
http://dx.doi.org/10.1186/s13075-018-1515-1

Ejemplares similares